Department of Critical Care Medicine, Hospital for Sick Children, 7979University of Toronto, Toronto, ON, Canada.
Division of Cardiovascular Surgery, Hospital for Sick Children, 7979University of Toronto, Toronto, ON, Canada.
Perfusion. 2023 Mar;38(2):337-345. doi: 10.1177/02676591211054978. Epub 2022 Feb 10.
Del Nido cardioplegia (DNc) was designed for superior myocardial protection during cardiopulmonary bypass (CPB). We conducted a retrospective review to explore if DNc was associated with increase in systemic ventricle dysfunction (sVD) following pediatric CPB.
This single-center, retrospective study included 1534 patients undergoing CPB between 2013 and 2016, 997 prior to center-wide conversion to DNc and 537 following. The primary outcome was new postoperative ≥moderate sVD by echocardiogram. Secondary outcomes included sVD of any severity and right ventricular dysfunction. Data was evaluated by interrupted time-series analysis. Groups had similar cardiac diagnoses and surgical complexity. Del Nido cardioplegia was associated with longer median (IQR) CPB [117 (84-158) vs 108 (81-154), = 0.04], and aortic cross-clamp [83 (55-119) vs 76 (53-106), = 0.03], and fewer cardioplegia doses [2 (1-2) vs 3 (2-4), < 0.0001]. Mortality was similar in both groups. Frequency of sVD was unchanged following DNc, including predetermine subgroups (neonates, infants, and prolonged cross-clamp). Logistic regression showed a significant rise in right ventricular dysfunction (OR 5.886 [95% CI: 0.588, 11.185], = 0.03) but similar slope.
Use of DNc was not associated with increased in reported sVD, and provided similar myocardical protection to the systemic ventricle compared to conventional cardioplegia but may possibly impact right ventricular function. Studies evaluating quantitative systolic and diastolic function are needed.
Del Nido 心脏停搏液(DNc)旨在为体外循环(CPB)期间提供卓越的心肌保护。我们进行了一项回顾性研究,以探讨在儿科 CPB 后,DNc 是否与全身心室功能障碍(sVD)增加有关。
这项单中心、回顾性研究纳入了 2013 年至 2016 年期间接受 CPB 的 1534 例患者,其中 997 例在中心全面转换为 DNc 之前,537 例在之后。主要结局是新的术后超声心动图检查显示≥中度 sVD。次要结局包括任何严重程度的 sVD 和右心室功能障碍。通过中断时间序列分析评估数据。两组具有相似的心脏诊断和手术复杂性。DNc 组的 CPB 中位数(IQR)较长[117(84-158)比 108(81-154), = 0.04],主动脉阻断时间较长[83(55-119)比 76(53-106), = 0.03],心脏停搏液剂量较少[2(1-2)比 3(2-4), < 0.0001]。两组死亡率相似。DNc 后 sVD 的发生率保持不变,包括预定的亚组(新生儿、婴儿和延长的阻断时间)。Logistic 回归显示右心室功能障碍显著增加(OR 5.886 [95%CI:0.588, 11.185], = 0.03),但斜率相似。
使用 DNc 并未增加报告的 sVD,与传统心脏停搏液相比,对全身心室提供了相似的心肌保护,但可能对右心室功能产生影响。需要评估定量收缩和舒张功能的研究。